Literature DB >> 29535908

Small cell lung cancer: updates and new concepts.

Peter Ujhazy1, O Wolf Lindwasser2.   

Abstract

Entities:  

Year:  2018        PMID： 29535908      PMCID： PMC5835593          DOI： 10.21037/tlcr.2018.02.01

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  23 in total

1.  MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.

Authors:  Gurkan Mollaoglu; Matthew R Guthrie; Stefanie Böhm; Johannes Brägelmann; Ismail Can; Paul M Ballieu; Annika Marx; Julie George; Christine Heinen; Milind D Chalishazar; Haixia Cheng; Abbie S Ireland; Kendall E Denning; Anandaroop Mukhopadhyay; Jeffery M Vahrenkamp; Kristofer C Berrett; Timothy L Mosbruger; Jun Wang; Jessica L Kohan; Mohamed E Salama; Benjamin L Witt; Martin Peifer; Roman K Thomas; Jason Gertz; Jane E Johnson; Adi F Gazdar; Robert J Wechsler-Reya; Martin L Sos; Trudy G Oliver
Journal:  Cancer Cell       Date:  2017-01-12       Impact factor: 31.743

Review 2.  Cisplatin plus etoposide versus other platin-based regimens for patients with extensive small-cell lung cancer: a systematic review and meta-analysis of randomised, controlled trials.

Authors:  L Jiang; K-H Yang; Q-L Guan; D-H Mi; J Wang
Journal:  Intern Med J       Date:  2012-12       Impact factor: 2.048

Review 3.  Small cell lung cancer: will recent progress lead to improved outcomes?

Authors:  M Catherine Pietanza; Lauren Averett Byers; John D Minna; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2015-05-15       Impact factor: 12.531

4.  Results of the two incidence screenings in the National Lung Screening Trial.

Authors:  Denise R Aberle; Sarah DeMello; Christine D Berg; William C Black; Brenda Brewer; Timothy R Church; Kathy L Clingan; Fenghai Duan; Richard M Fagerstrom; Ilana F Gareen; Constantine A Gatsonis; David S Gierada; Amanda Jain; Gordon C Jones; Irene Mahon; Pamela M Marcus; Joshua M Rathmell; JoRean Sicks
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

Review 5.  Small cell lung cancer: where do we go from here?

Authors:  Lauren Averett Byers; Charles M Rudin
Journal:  Cancer       Date:  2014-10-21       Impact factor: 6.860

Review 6.  The role of radiation therapy in small cell lung cancer.

Authors:  Gregory M M Videtic
Journal:  Curr Oncol Rep       Date:  2013-08       Impact factor: 5.075

Review 7.  Progress in the management of limited-stage small cell lung cancer.

Authors:  Arya Amini; Lauren A Byers; James W Welsh; Ritsuko U Komaki
Journal:  Cancer       Date:  2013-12-10       Impact factor: 6.860

Review 8.  Small-cell lung cancer: what we know, what we need to know and the path forward.

Authors:  Adi F Gazdar; Paul A Bunn; John D Minna
Journal:  Nat Rev Cancer       Date:  2017-10-27       Impact factor: 60.716

Review 9.  Systemic therapy for small cell lung cancer.

Authors:  Benjamin Levy; Ashish Saxena; Bryan J Schneider
Journal:  J Natl Compr Canc Netw       Date:  2013-07       Impact factor: 11.908

10.  Perspective: Opportunities in recalcitrant, rare and neglected tumors.

Authors:  Beverly A Teicher
Journal:  Oncol Rep       Date:  2013-07-02       Impact factor: 3.906
View more
  5 in total

1.  Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.

Authors:  Demetra P Kelenis; Kathia E Rodarte; Rahul K Kollipara; Karine Pozo; Shreoshi Pal Choudhuri; Kyle B Spainhower; Sarah J Wait; Victor Stastny; Trudy G Oliver; Jane E Johnson
Journal:  Cancer Res       Date:  2022-09-02       Impact factor: 13.312

2.  EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer.

Authors:  Victoria Foy; Colin R Lindsay; Alexandra Carmel; Fabiola Fernandez-Gutierrez; Matthew G Krebs; Lynsey Priest; Mathew Carter; Harry J M Groen; T Jeroen N Hiltermann; Antonella de Luca; Francoise Farace; Benjamin Besse; Leon Terstappen; Elisabetta Rossi; Alessandro Morabito; Francesco Perrone; Andrew Renehan; Corinne Faivre-Finn; Nicola Normanno; Caroline Dive; Fiona Blackhall; Stefan Michiels
Journal:  Transl Lung Cancer Res       Date:  2021-04

3.  Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer.

Authors:  Franziska Böttger; Ekaterina A Semenova; Ji-Ying Song; Giustina Ferone; Jan van der Vliet; Miranda Cozijnsen; Rajith Bhaskaran; Lorenzo Bombardelli; Sander R Piersma; Thang V Pham; Connie R Jimenez; Anton Berns
Journal:  Cell Rep       Date:  2019-06-11       Impact factor: 9.423

4.  Subtype-specific secretomic characterization of pulmonary neuroendocrine tumor cells.

Authors:  Xu-Dong Wang; Rongkuan Hu; Qing Ding; Trisha K Savage; Kenneth E Huffman; Noelle Williams; Melanie H Cobb; John D Minna; Jane E Johnson; Yonghao Yu
Journal:  Nat Commun       Date:  2019-07-19       Impact factor: 14.919

5.  Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce.

Authors:  Harriet M Kluger; Hussein A Tawbi; Maria L Ascierto; Michaela Bowden; Margaret K Callahan; Edward Cha; Helen X Chen; Charles G Drake; David M Feltquate; Robert L Ferris; James L Gulley; Shilpa Gupta; Rachel W Humphrey; Theresa M LaVallee; Dung T Le; Vanessa M Hubbard-Lucey; Vassiliki A Papadimitrakopoulou; Michael A Postow; Eric H Rubin; Elad Sharon; Janis M Taube; Suzanne L Topalian; Roberta Zappasodi; Mario Sznol; Ryan J Sullivan
Journal:  J Immunother Cancer       Date:  2020-03       Impact factor: 13.751
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.